Ora Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ora Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10533
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ora Inc (Ora) is an ophthalmic contract research organization that provides clinical research and drug development services. The organization offers pre-clinical research, animal toxicology studies, and compounds identification and procurement services. It offers clinical study project management services, which include protocol writing, site start-up, site management, vendor management, clinical monitoring, medical monitoring, and biostatistics. Ora provides clinical developmental solutions in the areas of ophthalmic such as allergy, allergic rhinitis, dry eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery and devices. The organization provides drug development services in the areas of dry eye, allergy, glaucoma, anti-infective, anti-inflammatory, and retinal ophthalmic treatments. It also offers preclinical development services including study design and execution. The organization operates offices in the US and Japan. Ora is headquartered in Andover, Massachusetts, the US.

Ora Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ora Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ora Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ora Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ora Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ora Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ora Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ora Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AXIM Biotech Enters into Agreement with Ora 11
Okogen Enters into Agreement with Ora 12
Portola Pharma Enters into Co-Development Agreement with Ora for PRT2761 13
Licensing Agreements 14
Ora Enters into Licensing Agreement with Nicox Ophthalmics 14
Achillion Pharma Enters into Licensing Agreement with Ora 15
ORA Enters into Sublicense Agreement with Taejoon Pharm 16
Ora Inc – Key Competitors 17
Ora Inc – Key Employees 18
Ora Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Product News 20
Mar 21, 2017: Medical Marijuana Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Ora Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ora Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ora Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ora Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ora Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ora Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ora Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AXIM Biotech Enters into Agreement with Ora 11
Okogen Enters into Agreement with Ora 12
Portola Pharma Enters into Co-Development Agreement with Ora for PRT2761 13
Ora Enters into Licensing Agreement with Nicox Ophthalmics 14
Achillion Pharma Enters into Licensing Agreement with Ora 15
ORA Enters into Sublicense Agreement with Taejoon Pharm 16
Ora Inc, Key Competitors 17
Ora Inc, Key Employees 18
Ora Inc, Subsidiaries 19

List of Figures
Ora Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ora Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ora Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ora Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ora Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ora Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ora Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ora Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ora Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ora Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cargill, Incorporated:企業のM&A・事業提携・投資動向
    Cargill, Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cargill, Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Nanolek-製薬・医療分野:企業M&A・提携分析
    Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek a …
  • Natrix Separations Inc-製薬・医療分野:企業M&A・提携分析
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies is a medical device company that provides disposable products. The company’s products line comprise HD-Q membrane adsorbers and bind-elute products. Its HD-Q membrane adsorbers finds application in single-use flow-through p …
  • MTU Aero Engines Holdings AG (MTX):企業の財務・戦略的SWOT分析
    MTU Aero Engines Holdings AG (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Callitas Therapeutics Inc (LILY):製薬・医療:M&Aディール及び事業提携情報
    Summary Callitas Therapeutics Inc (Callitas Therapeutics), formerly M Pharmaceutical Inc, is a drug discovery and development company that offers ground-breaking drug treatments and biomedical technologies. The company’s products include weight management products, infertility products and women’s h …
  • Creightons plc:企業の戦略・SWOT・財務情報
    Creightons plc - Strategy, SWOT and Corporate Finance Report Summary Creightons plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Orascom Development Egypt Sae:企業の戦略・SWOT・財務分析
    Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report Summary Orascom Development Egypt Sae - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Michael J Fox Foundation for Parkinson’s Research:医療機器:M&Aディール及び事業提携情報
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments …
  • Arcato Laboratories Inc-医療機器分野:企業M&A・提携分析
    Summary Arcato Laboratories Inc (Arcato Laboratories) is an oral health company that commercializes proprietary oral care products for specialty healthcare. The company’s product includes OraWax, a medical device that is used for the treatment of irritation and oral discomfort caused from the use of …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Forestar Group Inc:企業の戦略・SWOT・財務分析
    Forestar Group Inc - Strategy, SWOT and Corporate Finance Report Summary Forestar Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nippon Flour Mills Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • IntegraGen SA (ALINT):医療機器:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …
  • Southern Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Southern Research Institute (Southern Research) is a contract research organization which conducts research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. Its life science services include preclinical drug development, basic r …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ingram Entertainment Inc.:企業の戦略的SWOT分析
    Ingram Entertainment Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆